UMIN ID: C000000342
Registered date:01/03/2006
Japan Antiphospholipid syndrome-Stroke Prevention Study
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Antiphospholipid syndrome |
Date of first enrollment | 2006/03/31 |
Target sample size | 100 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Warfarin, INR 2.0, 2 years cilostazol, 200mg/day, 2 years or ticlopidine, 100-200mg/day, 2 years |
Outcome(s)
Primary Outcome | Cerebral Infarct Score in MRI |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Female patients who are pregnant or plans to be pregnant Patients who cannot have warfarin or antiplatetet drugs Patients who are required to take warfarin Patients with severe hepatic, renal or cardiac failure Other inadequate patients for this clinical trial |
Related Information
Primary Sponsor | JASPRES team |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Health and Labour Sciences Research Grants |
Secondary ID(s) |
Contact
public contact | |
Name | Tatsuya Atsumi |
Address | N14 W5, Kita-ku, Sapporo Japan |
Telephone | 011-706-5915 |
at3tat@med.hokudai.ac.jp | |
Affiliation | Hokkaido University Hospital Medicine II |
scientific contact | |
Name | Tatsuya Atsumi |
Address | N14 W5, Kita-ku, Sapporo Japan |
Telephone | 011-706-5915 |
Affiliation | Hokkaido University Hospital Medicine II |